Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 29, Issue 1, Pages 34-42
Publisher
Springer Nature
Online
2015-10-30
DOI
10.1038/modpathol.2015.123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Recurrent Copy Number Alterations and Cancer Gene Mutations on the Predictive Accuracy of Prognostic Models in Clear Cell Renal Cell Carcinoma
- (2014) A. Ari Hakimi et al. JOURNAL OF UROLOGY
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
- (2014) Alexander Sankin et al. Cancer Medicine
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
- (2013) Adam M. Fontebasso et al. ACTA NEUROPATHOLOGICA
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma
- (2013) Richard W. Joseph et al. CANCER
- Cooperation and Antagonism among Cancer Genes: The Renal Cancer Paradigm
- (2013) S. Pena-Llopis et al. CANCER RESEARCH
- The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutSα
- (2013) Feng Li et al. CELL
- Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
- (2013) J. M. Simon et al. GENOME RESEARCH
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
- (2013) Sam Behjati et al. NATURE GENETICS
- Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
- (2013) Lynn Bjerke et al. Cancer Discovery
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers
- (2010) Michiel Vermeulen et al. CELL
- Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling
- (2010) M. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Alternative Splicing by Histone Modifications
- (2010) R. F. Luco et al. SCIENCE
- External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
- (2008) Richard Zigeuner et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now